Skip to content

Lit review finds ‘significant link’ between cannabis use and onset of mania symptoms.

Researchers from the University of Warwick have found evidence to suggest a significant relationship between cannabis use and the onset and exacerbation of mania symptoms.  The researchers carried out a review of scientific literature examining the effect of cannabis use. The literature sampled 2,391 individuals who had experienced mania symptoms.

Mania symptoms are part of bipolar disorder and can include feelings of persistent elation, heightened energy and hyperactivity and a reduced need for sleep. Mania can also make people feel angry and aggressive with extreme symptoms including becoming delusional or hearing voices.

The team state that previously it has been unclear whether cannabis use predates manic episodes.  The group wanted to answer two questions, does cannabis use lead to increased occurrence of mania symptoms or manic episodes in individuals with pre-existing bipolar disorder? But also, does cannabis use increase the risk of onset of mania symptoms in those without pre-existing bipolar disorder?”

The researchers looked at a number of previous studies and concluded that cannabis use preceded the onset of mania symptoms.

The team explain that the observed tendency for cannabis use to precede or coincide with rather than follow mania symptoms, and the more specific association between cannabis use and new onset manic symptoms, suggests potential causal influences from cannabis use to the development of mania. It is a significant link.  The review suggested that cannabis use significantly worsened mania symptoms in people who had previously been diagnosed with bipolar disorder.

The team summise that there are limited studies addressing the association of cannabis use and manic symptoms, which suggests this is a relatively neglected clinical issue. However the review suggests that cannabis use is a major clinical problem occurring early in the evolving course of bipolar disorder. More research is needed to consider and image specific pathways from cannabis use to mania and how these may be effected by genetic vulnerability and environmental risk factors.

Cannabis is the most prevalent drug used by the under-18s and during this critical period of development services should be especially aware of and responsive to the problems that cannabis use can cause for adolescent populations.

Source:  University of Warwick

 

Thalamic surface shape differences. (A) Control subjects with a history of cannabis use disorder (CON-CUD) contrasted with control subjects with no history of substance use disorders (CON-Clean), (B) schizophrenia subjects with no history of substance use disorders (SCZ-Clean) contrasted with CON-Clean, (C) schizophrenia subjects with a history of cannabis use disorder (SCZ-CUD) contrasted with SCZ-Clean. T-values with cooler colors (T  0) indicate outward shape differences.  Cannabis-Related Working Memory Deficits and Associated Subcortical Morphological Differences in Healthy Individuals and Schizophrenia Subjects.  Csernansky et al 2013.
Thalamic surface shape differences. (A) Control subjects with a history of cannabis use disorder (CON-CUD) contrasted with control subjects with no history of substance use disorders (CON-Clean), (B) schizophrenia subjects with no history of substance use disorders (SCZ-Clean) contrasted with CON-Clean, (C) schizophrenia subjects with a history of cannabis use disorder (SCZ-CUD) contrasted with SCZ-Clean. T-values with cooler colors (T 0) indicate outward shape differences. Cannabis-Related Working Memory Deficits and Associated Subcortical Morphological Differences in Healthy Individuals and Schizophrenia Subjects. Csernansky et al 2013.

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

One thought on “Lit review finds ‘significant link’ between cannabis use and onset of mania symptoms. Leave a comment

  1. This is identical to a side effect of major concern in virtually ALL effective Antidepressant Pharmaceuticals, and Herbals (i.e, St. John’s Wort), if this “meta-analysis” (Monte Carlo simulations or “runs” of existing data –in this case correlational data with a wide range of varying reliability and validity) demonstrates ANYTHING –it is that CANNABINOIDS, and indeed cannabis itself, should be studied (screened) for antidepressant efficacy, starting with preclinical animal models such as forced swim, Chronic Unpredictable Stress, etc.

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.